ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    The mTORC2 Activation Is Critical for Hepato-Cytoprotection Against Ischemia and Reperfusion Injury.

    H. Zhou,1,2 J. Zhu,1,3 S. Yue,1 R. Busuttil,1 J. Kupiec-Weglinski,1 X. Wang,2 Y. Zhai.1

    1Surgery, David Geffen School of Medicine-University of California-Los Angeles, LA, CA; 2Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China; 3Liver Surgery, Renji Hospital, Shanghai, China.

    Background & AimsRapamycin and Everolimus have been used in liver transplant patients, particularly those with calcineurin inhibitor-related nephrotoxicity and hepatocellular carcinoma. Although designed as mTORC1…
  • 2016 American Transplant Congress

    Heparanase: A New Factor Involved in the Pro-Fibrotic Renal Biological Machinery Activated by the Ischemia/Reperfusion (I/R) Injury.

    G. Zaza,1 V. Masola,1 G. Gambaro,2 M. Onisto,3 G. Bellin,1 I. Vlodavsky,4 Z. Abassi,5 A. Lupo.1

    1Renal Unit, Department of Medicine, University of Verona, Verona, Italy; 2Division of Nephrology and Dialysis, Columbus-Gemelli Hospital Catholic University, Rome, Italy; 3Department of Biomedical Sciences, University of Padova, Padova, Italy; 4Cancer and Vascular Biology Research Center, Rappapor Faculty of Medicine, Technion, Haifa, Israel, Italy; 5Department of Physiology and Biophysics, Rappaport Faculty of Medicine, Technion, Haifa, Israel, Italy.

    Ischemia/reperfusion (I/R) is an important cause of acute renal failure and delayed graft function, and it may induce chronic renal damage by activating epithelial to…
  • 2016 American Transplant Congress

    Adding Anti-Inflammatory Agents During Normothermic Ex-Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation.

    N. Goldaracena, E. Juan, K. Moritz, V. Spetzler, A. Barbas, D. Grant, M. Selzner.

    Multi Organ Transplant Program, Toronto General Hospital, Toronto, Canada.

    Introduction: Normothermic ex vivo liver perfusion (NEVLP) improves graft preservation by avoiding cold ischemic injury. We investigated if protective effects of NEVLP can be further…
  • 2016 American Transplant Congress

    Role of TGF-β in Ischemia and Reperfusion Injury Induced Renal Fibrosis in Human Proximal Tubular Epithelial Cells.

    R. Kapoor, N. Sheerin, J. Kirby.

    Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.

    Ischemia-reperfusion injury (IRI) leads to an irreversible damage to the tubular epithelium and promotes acute kidney injury (AKI) that is associated with progressive loss of…
  • 2016 American Transplant Congress

    Subnormothermic Machine Perfusion (SNMP) of Liver Allografts with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Increases β-Oxidation of Fatty Acids and Decreases Lipid Peroxidation (LP).

    B. Banan, R. Lopez, C. Hughes, G. Michalopoulos, P. Fontes.

    University of Pittsburgh, Pittsburgh.

    Introduction: There is limited information about the lipid metabolic profile during liver allograft preservation. LP remains a major component of ischemia-reperfusion injuries (IRIs). The aim…
  • 2016 American Transplant Congress

    CD9+ Regulatory B Lymphocytes Control Chronic Lung Inflammation by Inducing Effector T Cell Apoptosis.

    C. Brosseau,1,2 M. Durand,1 F. Braza,1 E. Durand,2 J. Loy,2 P. Lacoste,2 P. Royer,2 M.-A. Cheminant,2 A. Magnan,2 S. Brouard.1

    1ITUN-INSERM U1064, Nantes, France; 2Institut du thorax, INSERM U1087/CNRS U6291, Nantes, France.

    Several observations highlight the relevance of regulatory B cells (Breg) to clinical transplantation. We have identified a new Breg population expressing the CD9, able to…
  • 2016 American Transplant Congress

    Gene Expression Microarray Analysis of Purified CD16-Stimulated Human NK Cells and Indication Biopsies Supports a CD16-Mediated Role for NK Cells in Antibody-Mediated Kidney Rejection.

    M. Parkes,1 P. Halloran,1 L. Hidalgo.2

    1Dept. of Medicine, University of Alberta, Edmonton, AB, Canada; 2Dept. of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada.

    BACKGROUND: CD16α mediates NK cell responses to donor-specific IgG antibodies (DSA), and shares mechanisms with effector T cell receptor (TCR) stimulation. Whether CD16α-inducible transcripts are…
  • 2016 American Transplant Congress

    PD-L1/PD-L2-Expressing B-1a Cells Inhibit Allo-Reactive T Cells in Mice.

    T. Hirose,1,2 Y. Tanaka,1 H. Ohdan.1

    1Transplant Surgery, Hiroshima University, Hiroshima, Japan; 2Urology, Hokkaido University, Sapporo, Hokkaido, Japan.

    Donor lymphocyte infusion (DLI) induces donor-specific hypo responsiveness or immune-tolerance among allo-reactive T cells in different organ transplantation models. However, the optimal cell source or…
  • 2016 American Transplant Congress

    Cross-Talk Between TLR and BCR Pathways Induces CNI-Resistance in B-Cells Responding to Blood Group A-Antigens: A Novel Paradigm for Treatment with TLR-Inhibitor for CNI-Resistant AMR.

    H. Sakai, Y. Tanaka, H. Ohdan.

    Hiroshima University, Hiroshima, Japan.

    [Aim] Bacterial infections after ABO-incompatible transplantation are associated with refractory antibody (Ab)-mediated rejection (AMR). We demonstrated that bacterial pathogens provoke B cells, responding to human…
  • 2016 American Transplant Congress

    Limited Efficacy of Bortezomib on Desensitization via Rapid Humoral Compensation in a Sensitized Rhesus Model.

    J. Kwun,1 C. Burghuber,1 N. Iwakoshi,2 A. Gibby,2 S. Knechtle.1

    1Surgery, Duke University, Durham; 2Surgery, Emory University, Atlanta.

    Sensitized patients comprise a significant proportion (30%) of candidates on the waiting list for transplantation. With recent evidence that the presence of donor-specific antibodies (DSA)…
  • « Previous Page
  • 1
  • …
  • 1174
  • 1175
  • 1176
  • 1177
  • 1178
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences